Manulife (Manufacturers Life Insurance)
FBRX icon

Manulife (Manufacturers Life Insurance)’s Forte Biosciences FBRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-556
Closed -$41K – 3135
2021
Q3 		$41K Buy
556
+285
+105% +$158K ﹤0.01% 3124
2021
Q2 		$228K Buy
+271
New +$244K ﹤0.01% 3012
2019
Q3 		– Sell
-42
Closed -$106K – 2893
2019
Q2 		$106K Buy
+42
New +$125K ﹤0.01% 2875
2018
Q3 		– Sell
-1
Closed -$2K – 3216
2018
Q2 		$2K Sell
1
-37
-97% -$135K ﹤0.01% 4200
2018
Q1 		$167K Sell
38
-2
-5% -$9.26K ﹤0.01% 3148
2017
Q4 		$155K Buy
40
+38
+1,900% +$152K ﹤0.01% 3200
2017
Q3 		$9K Buy
+2
New +$8.91K ﹤0.01% 3860

Other funds holding FBRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s FBRX Position: Q4 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Forte Biosciences (FBRX) in Q4 2021, closing a stake of 556 shares — an estimated $41K sold.

Manulife (Manufacturers Life Insurance) first reported a position in FBRX in Q3 2017 and held it in 7 quarters. The position peaked at $228K in Q2 2021. 52 funds tracked by Wall St. Rank hold FBRX as of Q4 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Forte Biosciences position as of Q4 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 556 Forte Biosciences shares in Q4 2021, an estimated $41K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Forte Biosciences in Q3 2017 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s Forte Biosciences position peaked at $228K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2021, filed 16 Feb 2022.